Navigation Links
Don't Skip This Year's Flu Shot: CDC
Date:8/18/2011

By Denise Mann
HealthDay Reporter

THURSDAY, Aug. 18 (HealthDay News) -- The 2011-12 flu vaccine protects against seasonal flu and H1N1, just like last year's, but that doesn't mean it's OK to skip your yearly flu shot, researchers from the U.S. Centers for Disease Control and Prevention warn.

"All people aged 6 months and older should be vaccinated," said Dr. Carolyn Bridges, an associate director for adult immunization at the CDC's National Center for Immunization and Respiratory Diseases.

Protection wanes over the course of a year, so "even people who got a flu vaccine last year should get one again to make sure they are optimally protected," she said.

The new recommendations are published in the Aug. 18 issue of the CDC's Morbidity and Mortality Weekly Report.

The fact that the vaccines are identical does change things slightly for children aged 6 months to 8 years. In general, children in this age range should get two doses of the flu shot administered at least four weeks apart, but they will only need one dose of the 2011-2012 vaccine if they received at least one dose in 2010-2011.

Children in that age range who did not get the flu vaccine last year need two doses this season.

The vaccine formulation was recommended by the World Health Organization, and six manufacturers have been chosen to produce and distribute the vaccines for the United States.

The brand names and manufacturers of the vaccines are: Afluria, CSL Limited; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; FluMist, MedImmune Vaccines Inc.; Fluvirin, Novartis Vaccines and Diagnostics Limited; and Fluzone, Fluzone High-Dose and Fluzone Intradermal, Sanofi Pasteur Inc.

New this year is an intradermal flu vaccine, Fluzone Intradermal, which will be available for adults aged 18 through 64 years. This vaccine is delivered into the skin, rather than the muscle, using a very small needle, according to the U.S. Food and Drug Administration, which approved it in May.

Last month, the CDC said the targeted flu strains for 2011-2012 are:

  • A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus
  • A/Perth/16/2009 (H3N2)-like virus
  • B/Brisbane/60/2008-like virus

Dr. Lisa Grohskopf, an epidemiologist at the CDC's National Center for Immunization and Respiratory Diseases, stressed the importance of getting the 2011-2012 flu vaccine. "If we are looking on an individual basis, we can't tell how quickly antibodies will decay after the vaccine, but we do know that immune response will drop over the course of a year," she said. "You can't count on that vaccine protecting you for a second season."

More information

The U.S. Centers for Disease Control and Prevention has more on the 2011-2012 flu vaccine.

SOURCES: Lisa Grohskopf, M.D., M.P.H., epidemiologist, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta; Carolyn Bridges, M.D., associate director, adult immunization, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention; Aug. 18, 2011, Morbidity and Mortality Weekly Report


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Periodontal pathogens enhance HIV-1 promoter activation in T cells
2. Successful treatment of periodontal disease lowered preterm birth incidences
3. National Prosthodontics Awareness Week Serves and Educates Consumers About Proper Oral Health Care
4. EDS Announces New SafeSiders Endodontic Glide Path Kit
5. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
6. Researchers study relationship of oral cancers and periodontal disease
7. Successful periodontal therapy may reduce the risk of preterm birth, according to Penn dental study
8. Orthodontic Retainers Can Harbor Harmful Microbes
9. “Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans
10. The Foundation of the American Academy of Ophthalmology's Museum of Vision Celebrates 30 Years of Preserving Ophthalmic Heritage
11. Material tested that could guarantee body protheses for more than 150 years
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Don't Skip This Year's Flu Shot:  CDC 
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Building on the ... Louisiana became the sixth state to pass legislation which ensures that children can ... signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah and Washington who ...
(Date:6/27/2017)... ... 2017 , ... The Kelahan Agency, a privately owned firm ... southern New Hampshire, is teaming up with the New Horizons for New Hampshire ... the region. , New Horizons for New Hampshire provides a wealth of services ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: